229 related articles for article (PubMed ID: 16491556)
1. [Now no new drugs will be developed!].
Lafolie P
Lakartidningen; 2006 Jan 25-31; 103(4):225. PubMed ID: 16491556
[No Abstract] [Full Text] [Related]
2. Brand versus generic medications: the money, the patient and the research.
Blier P
J Psychiatry Neurosci; 2003 May; 28(3):167-8. PubMed ID: 12790156
[No Abstract] [Full Text] [Related]
3. [Parallel import of drugs for better and for worse].
Krabbe U
Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
[No Abstract] [Full Text] [Related]
4. Drug importation and safety of drugs obtained from Canada.
Shepherd M
Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
[TBL] [Abstract][Full Text] [Related]
5. Who's really raising drug prices?
Zagorin A
Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
[No Abstract] [Full Text] [Related]
6. Prescription drugs and health care reform.
Gibaldi M
Pharmacotherapy; 1993; 13(6):583-9. PubMed ID: 8302681
[No Abstract] [Full Text] [Related]
7. AWP reimbursement scrutinized by several states.
Carroll J
Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
[No Abstract] [Full Text] [Related]
8. [Generic medicines].
Peláez de Loño J
Rev Enferm; 1999 Dec; 22(12):836-43. PubMed ID: 10797771
[TBL] [Abstract][Full Text] [Related]
9. RX for nosebleed prices.
Greenwald J
Time; 2001 May; 157(20):42-3. PubMed ID: 11383109
[No Abstract] [Full Text] [Related]
10. The impact of generic substitution on price competition in Finland.
Aalto-Setälä V
Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
[TBL] [Abstract][Full Text] [Related]
11. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.
Sherrid P
US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929
[No Abstract] [Full Text] [Related]
12. The importance of being first: evidence from Canadian generic pharmaceuticals.
Hollis A
Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
[TBL] [Abstract][Full Text] [Related]
13. Clinton team works with drug companies to expand access, restrict costs.
Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
[No Abstract] [Full Text] [Related]
14. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
Alván G
Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
[No Abstract] [Full Text] [Related]
15. Lowering the cost of prescription drugs.
Jindal B
J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
[No Abstract] [Full Text] [Related]
16. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing?
Sturm AC
Healthc Financ Manage; 2006 Nov; 60(11):120-2. PubMed ID: 17094287
[No Abstract] [Full Text] [Related]
17. [Same drugs same names].
Lønkvist HB
Ugeskr Laeger; 2004 Apr; 166(17):1583. PubMed ID: 15146696
[No Abstract] [Full Text] [Related]
18. Vertical integration: the drug industry and prescription benefits managers.
Gibaldi M
Pharmacotherapy; 1995; 15(3):265-71. PubMed ID: 7667161
[No Abstract] [Full Text] [Related]
19. Therapeutic-class wars--drug promotion in a competitive marketplace.
Kessler DA; Rose JL; Temple RJ; Schapiro R; Griffin JP
N Engl J Med; 1994 Nov; 331(20):1350-3. PubMed ID: 7935706
[No Abstract] [Full Text] [Related]
20. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Woolner D
N Z Bioeth J; 2003 Oct; 4(3):22, 25-6. PubMed ID: 15597481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
